Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Capital Leases: 2023-2024

Historic Capital Leases for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2024 value amounting to $310,000.

  • Cidara Therapeutics' Capital Leases fell 46.09% to $310,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $310,000, marking a year-over-year decrease of 46.09%. This contributed to the annual value of $310,000 for FY2024, which is 46.09% down from last year.
  • Per Cidara Therapeutics' latest filing, its Capital Leases stood at $310,000 for FY2024, which was down 46.09% from $575,000 recorded in FY2023.
  • Cidara Therapeutics' 5-year Capital Leases high stood at $575,000 for FY2023, and its period low was $310,000 during FY2024.
  • Its 2-year average for Capital Leases is $442,500, with a median of $442,500 in 2023.
  • Data for Cidara Therapeutics' Capital Leases shows a maximum YoY slumped of 46.09% (in 2024) over the last 5 years.
  • Cidara Therapeutics' Capital Leases (Yearly) stood at $575,000 in 2023, then plummeted by 46.09% to $310,000 in 2024.